References
-
1
Ascher J A, Cole J O, Colin J N, Feighner J P, Ferris R M, Fibiger H C, Golden R N, Martin P, Potter W Z, Richelson E. et al .
Bupropion: a review of its mechanism of antidepressant activity.
J Clin Psychiatry.
1995;
2 (9)
395-401
-
2
Grohmann R, Rüther E, Engel R R, Hippius H.
Assessment of adverse drug reactions in psychiatric inpatients with the AMSP drug safety program: methods and first results for tricyclic antidepressants and SSRI.
Pharmacopsychiatry.
1999;
32
21-28
-
3
Hurt R D, Sachs D PL, Glover E D. et al .
A comparison of sustained-release bupropion and placebo for smoking cessation.
N Engl J Med.
1997;
337
1195-1202
-
4
Johnston J A, Lineberry C G, Ascher J A,. et al .
A 102-center prospective study of seizure in association with bupropion.
J Clin Psychiatry.
1991;
52
450-456
-
5
Jorenby D E, Leischow S J, Nides M A. et al .
A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.
N Engl J Med.
1999;
340
685-691
-
6
Nomikos G G, Damsma G, Wenkstern D, Fibiger H C.
Acute effects of bupropion on extracellular dopamine concentrations in rat striatum and nucleus accumbens studied by in vivo microdialysis.
Neuropsychopharmacology.
1989;
2 (4)
273-279
-
7
Ramcharitar V, Levine B S, Goldberger B A, Caplan Y H.
Bupropion and alcohol fatal intoxication: case report.
Forensic Sci Int.
1992;
56 (2)
151-156
Prof. Dr. G. Laux
Ärztlicher Direktor
Bezirksklinikum Gabersee
83512 Wasserburg/Inn
